Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Correction: Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease activity: A prospective, non-randomized pilot study

  • Garrick D. Talmage,
  • Oscar J. M. Coppes,
  • Adil Javed,
  • Jacqueline Bernard

Correction: Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease activity: A prospective, non-randomized pilot study

  • Garrick D. Talmage, 
  • Oscar J. M. Coppes, 
  • Adil Javed, 
  • Jacqueline Bernard
PLOS
x

There are errors in the author affiliations. The affiliations should appear as shown here: Garrick D. Talmage1, Oscar J. M. Coppes2, Adil Javed3, Jacqueline Bernard4

1 Department of Otolaryngology, University of Colorado, Aurora, Colorado, United States of America, 2 Department of Anesthesia, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America, 3 Department of Neurology, The University of Chicago, Chicago, Illinois, United States of America, 4 Department of Neurology, Oregon Health Science University, Portland, Oregon, United States of America.

Reference

  1. 1. Talmage GD, Coppes OJM, Javed A, Bernard J (2017) Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease activity: A prospective, non-randomized pilot study. PLoS ONE 12(4): e0173299. https://doi.org/10.1371/journal.pone.0173299 pmid:28426702